General Information of Drug (ID: DMJ8UXO)

Drug Name
67Cu-SARTATE
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Phase 1/2 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
D0C2YZ

References

1 ClinicalTrials.gov (NCT04023331) 67Cu-SARTATE Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma. U.S. National Institutes of Health.